Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|March 18, 2015
[Immunotherapies and melanoma]Émilie Routier, Caroline Robert, Christina Mateus
La Revue Du Praticien|June 23, 2021
[Treatment of melanoma with immune checkpoints inhibitors]Jeremy Lupu, Pierre Hamann, Émilie Routier, et al.
Bulletin Du Cancer|December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.
Cancers|June 24, 2022
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in MelanomaAudrey Melin, Émilie Routier, Séverine Roy, et al.
JCO Precision Oncology|December 24, 2021
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 TherapyLéa Dousset, Florence Poizeau, Caroline Robert, et al.
The Lancet. Oncology|May 31, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations (EBIN): an international, open-label, randomised, controlled, phase 2 studyCaroline Robert, Michal Kicinski, Caroline Dutriaux, et al.
Pageof 1